Evidence map›Paper›PMID 41522807›Full record

ArticleOncology letters2026

Curative surgery enabled by radiotherapy in rectal cancer: A case report.

Sofia E Sánchez-De-Toca, Fernando Mendoza Moreno, Patricia Urbón Sánchez, Felix Mañes Jiménez, Yousef Allaoua Massaoui, Lucas Casalduero García, Pablo Barat Betrán, Alejandra Julia Lopez Marsellá, María Mejías Ledesma, Alberto Vilar Tabanera and 2 more

Abstract readCase Reports
In one paragraph

Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sofia E Sánchez-De-TocaDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, 28805 Madrid, Spain.
Fernando Mendoza MorenoDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, 28805 Madrid, Spain.
Patricia Urbón SánchezDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, 28805 Madrid, Spain.
Felix Mañes JiménezDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, 28805 Madrid, Spain.
Yousef Allaoua MassaouiDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, 28805 Madrid, Spain.
Lucas Casalduero GarcíaDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, 28805 Madrid, Spain.
Pablo Barat BetránDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, 28805 Madrid, Spain.
Alejandra Julia Lopez MarselláDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, 28805 Madrid, Spain.
María Mejías LedesmaDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, 28805 Madrid, Spain.
Alberto Vilar TabaneraDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, 28805 Madrid, Spain.
Manuel Diez AlonsoDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, 28805 Madrid, Spain.
Alberto Gutiérrez CalvoDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, 28805 Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neoadjuvant chemo-radiotherapy is the standard of care for patients with locally advanced rectal cancer. However, certain patients are ineligible for chemotherapy due to clinical contraindications such as active infections. Although neoadjuvant therapy remains the preferred approach, guidelines are limited for patients who cannot receive combined treatment. The present report describes a case in which radiotherapy alone, initiated with palliative intent, enabled complete surgical resection. A 46-year-old male patient presented with fever and proctalgia. Imaging revealed a large rectal mass associated with an ischiorectal abscess. Biopsy confirmed T4bN1 rectal adenocarcinoma. Chemotherapy was contraindicated due to ongoing infection; therefore, a diverting colostomy was performed. Short-course radiotherapy led to marked tumor regression. Subsequent pelvic exenteration achieved complete tumor removal. Postoperative wound dehiscence was managed successfully with vacuum-assisted closure therapy. No recurrence was observed on follow-up. The current case illustrates that radiotherapy alone may serve as a bridge to curative surgery in patients unfit for chemo-radiotherapy. The use of 3D reconstruction markedly improved preoperative planning and facilitated precise surgical resection. Additionally, perineal closure with Vicryl mesh and omental interposition minimized postoperative complications. In conclusion, in selected patients with contraindications to total neoadjuvant therapy, radiotherapy alone may be a feasible alternative to enable radical resection. Advanced surgical planning with 3D modeling can enhance outcomes in complex pelvic surgery.

Indexed as

3D reconstructionpelvic exenterationperineal reconstructionradiotherapyrectal cancer

Identifiers

PMID41522807
PMCPMC12784186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.